Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of Neuro-Oncology|March 25, 2006
Malignant epithelioid cranial nerve sheath tumor: case report of a radiation responseBarbara J Fisher, Kristopher E B DennisJournal of Neuro-Oncology|November 23, 2011
Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experienceJeffrey Q Cao, Barbara J Fisher, Glenn S Bauman, et al.International Journal of Radiation Oncology, Biology, Physics|April 18, 2002
Ki-67: a prognostic factor for low-grade glioma?Barbara J Fisher, Elitza Naumova, Christopher C Leighton, et al.International Journal of Radiation Oncology, Biology, Physics|February 15, 2015
Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Chen Hu, David R Macdonald, et al.International Journal of Radiation Oncology, Biology, Physics|August 17, 2021
Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal CancerLisa A Kachnic, Kathryn A Winter, Robert J Myerson, et al.International Journal of Radiation Oncology, Biology, Physics|December 2, 2019
High-risk Meningioma: Initial Outcomes From NRG Oncology/RTOG 0539C Leland Rogers, Minhee Won, Michael A Vogelbaum, et al.The New England Journal of Medicine|April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade GliomaJan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.American Journal of Clinical Oncology|January 28, 2020
Results of the NRG Oncology/RTOG 0848 Adjuvant Chemotherapy Question-Erlotinib+Gemcitabine for Resected Cancer of the Pancreatic Head: A Phase II Randomized Clinical TrialRoss A Abrams, Kathryn A Winter, Howard Safran, et al.International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.Pageof 2